CC - The Chemours Company
16.10 -0.14 (-0.86%)
After hours: 5:08PM EST
| Previous Close | 16.66 |
| Open | 16.71 |
| Bid | 16.10 x 1300 |
| Ask | 16.25 x 800 |
| Day's Range | 16.04 - 16.73 |
| 52 Week Range | 11.71 - 41.60 |
| Volume | 1,921,604 |
| Avg. Volume | 2,575,211 |
| Market Cap | 2.655B |
| Beta (5Y Monthly) | 2.48 |
| PE Ratio (TTM) | 6.78 |
| EPS (TTM) | 2.39 |
| Earnings Date | Feb 11, 2020 - Feb 16, 2020 |
| Forward Dividend & Yield | 1.00 (6.00%) |
| Ex-Dividend Date | Nov 12, 2019 |
| 1y Target Est | 22.92 |
- PR Newswire
Chemours Employees Celebrate Martin Luther King Jr. Day With Volunteer Projects Around The United States
Employees of The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies and chemical solutions, today volunteered at events in Delaware, New Jersey and Mississippi as part of Chemours' Fifth Annual Martin Luther King Jr. Day of Service.
- Zacks
Implied Volatility Surging for Chemours (CC) Stock Options
Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
- MarketWatch
House passes bill that could put 3M, other chemicals companies ‘on the hook for billions of dollars in cleanup fees’
The Democratic-led House of Representatives on Friday votes 247-159 in favor of a bill that aims to crack down on “forever chemicals” that have been linked to a range of health problems.
- Insider Monkey
How Did The Chemours Company (CC) Compare Against Hedge Fund Darlings in 2019?
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China. If you were a passive index fund investor, you had seen gains of 31% in your equity portfolio in 2019. However, if you were an […]
- InvestorPlace
7 Dividend Stocks to Buy to Kick Off the New Year
Yes, it is that time of the year again. When the calendar flips, everyone ponders what lies ahead, and resolutions for self-improvement are made; Often, to be broken later. Additionally, it is also a great time to re-examine your portfolio and consider adding in some new, income-oriented names -- including dividend stocks.While stocks overall are blasting to new highs, valuations are looking extended and things look vulnerable to a pullback. The catalyst will likely come when the Federal Reserve returns to a tightening bias, perhaps around March. When that happens, dividend stocks will provide a modicum of protection for equity investors when the volatility returns. * 10 2019 Winners That Will Be 2020 Losers With that in mind, take a look at these seven names to consider as we begin the new decade.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dividend Stocks to Buy: Macy's (M)Source: Chart courtesy of StockCharts.com Dividend Yield: 9.1%It's no secret that department stores are facing severe headwinds. However, retailers like Macy's (NYSE:M) are aggressively looking to revamp their value proposition to customers. This includes a new, second-hand thrift partnership with thredUP that provides lower cost options to bargain hunters searching for a deal.The company pays a dividend yield of 9.1%, and is enjoying a share price challenge of recent highs near the $17 per share level. The company will next report earnings results on Feb. 25 before the bell, and analysts are looking for earnings of $1.86 per share on revenues of around $8.3 billion. Duke Energy (DUK)Source: Chart courtesy of StockCharts.com Dividend Yield: 4.2%Duke Energy (NYSE:DUK) shares are pushing above their 50-day moving average, continuing a steady rise along its 200-day moving average that's been in play since the summer of 2018. The stock pays a 4.2% dividend yield, and has enjoyed recent analyst upgrades from Goldman Sachs and Barclays. Watch for a return to the prior high near $96-$97, which would be worth a gain of roughly 7% from here. * 7 High-Yield Dividend Stocks for Growth and Income in the 2020s The company will next report results on Feb. 13 before the bell, and analysts are looking for earnings of 89 cents per share on revenues of around $6.6 billion. Chemours Company (CC)Source: Chart courtesy of StockCharts.com Dividend Yield: 5.5%Shares of the The Chemours Company (NYSE:CC) are rounding higher off of a six-month trading range, and look ready for a push above their 200-day moving average for the first time since last April. The chemical company is behind familiar products like Teflon and Freon, and pays a 5.5% dividend yield.It will next report results on Feb. 13 after the close, and analysts are looking for earnings of 46 cents per share on revenues of $1.4 billion. Ford (F)Source: Chart courtesy of StockCharts.com Dividend Yield: 6.4%Shares of Ford (NYSE:F) are consolidating above their 200-day moving average as of late. The company looks ready for a rally to prior highs near $10.20, which would be worth a gain of roughly 10% from here. Ford has been in the news recently for its Mustang Mach-E First Edition electric vehicle, with reservations full. This seems like a sign that the company could take some electric vehicle market share away from Tesla. * 7 Tech Stocks to Buy As the Trade War Ends The company will next report results on Feb. 4 after the close, and analysts are looking for earnings of 17 cents per share on revenues of $36.7 billion. Shares pay a 6.4% dividend yield. Exxon Mobil (XOM)Source: Chart courtesy of StockCharts.com Dividend Yield: 4.9%Exxon Mobil (NYSE:XOM) shares are rising up and out of a six-month consolidation pattern with a run towards its 200-day moving average. Oil prices have been on the move lately, with West Texas Intermediate rising from a low of $51-$52 per share to return to push towards $62 amid the rise of renewed tensions in the Middle East.The company pays a 4.9% dividend yield and will next report results on Jan. 31 before the bell. Analysts are looking for earnings of 73 cents per share on revenues of $63.6 billion. General Motors (GM)Source: Chart courtesy of StockCharts.com Dividend Yield: 4.1%Shares of General Motors (NYSE:GM) are rising back up and over their 200-day moving average, and look ready to test the upper end of a three-year trading range. In early December, the company announced plans to mass-produce battery cells for electric vehicles in collaboration with LG Chem. Together, the companies intend to invest a total of $2.3 billion by 2023 to establish a new battery factory in northeast Ohio. * 5 Hot Housing Stocks That Could Stay Hot in 2020 The company will next report results on Feb. 5 before the bell, and analysts are looking for earnings of seven cents per share on revenues of $30.8 billion. The company pays a 4.1% dividend yield. Kohl's (KSS)Source: Chart courtesy of StockCharts.com Dividend Yield: 5.5%Kohl's (NYSE:KSS) shares are in the midst of a sideways consolidation range going back to May, but look ready for an attempt to push up and over its 200-day moving average. That would open the door to a test of prior highs near $78, which would be worth a gain of roughly 60% from here.The company pays a 5.5% dividend yield and will next report results on May 3 before the bell. Analysts are looking for earnings of $1.97 per share on revenues of $6.6 billion.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 2019 Winners That Will Be 2020 Losers * 5-Year Returns for 5 Dow Jones Stocks Entering 2020 * 5 Semiconductor Stocks to Buy for Big Gains In 2020 The post 7 Dividend Stocks to Buy to Kick Off the New Year appeared first on InvestorPlace.
- Simply Wall St.
Here's How We Evaluate The Chemours Company's (NYSE:CC) Dividend
Dividend paying stocks like The Chemours Company (NYSE:CC) tend to be popular with investors, and for good reason...
- PR Newswire
Chemours announces suspension of high-GWP refrigerants R-404A and R-507A supply in the EU as of January 1, 2020
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts, and chemical solutions announced today that to support the market transition driven by the European Union F-Gas regulation to lower GWP alternatives and prepare for the next quota phasedown in 2021, the company will be suspending supply of high GWP refrigerants R-404A (GWP 3922) and R-507A (GWP 3985) in the European Union as of January 1, 2020.
- GuruFocus.com
Top Undervalued Companies Owned by Activist Investors, Part 2
Complications from spinoffs and mergers have eroded these companies’ share prices Continue reading...
- Bloomberg
DuPont’s Breakups Only Lead to More Breakups
(Bloomberg Opinion) -- Round and round the DuPont merry-go-round of financial engineering we go.The chemicals giant agreed on Sunday to sell its nutrition and biosciences division to International Flavors & Fragrances Inc. via a tax-friendly Reverse Morris Trust transaction that values the business at about $26 billion. DuPont de Nemours Inc. will receive a one-time $7.3 billion cash payment and its shareholders will own 55.4% of the combined entity.This is just the latest in a long line of dealmaking by DuPont chairman Ed Breen, who earned the respect of the investing world for salvaging Tyco International from scandal in part by breaking it up several times.(1) At DuPont, he’s helped orchestrate a complicated merger with rival Dow Chemical and a subsequent three-way split. After some rejiggering of the combined companies’ various assets amid pushback from activist investors, DuPont this year spun off the Dow Inc. commodity-chemical business and the Corteva Inc. agricultural-products company. Breen may not be done tinkering with DuPont’s portfolio after the International Flavors deal; Bloomberg News has reported that DuPont is also evaluating a divestiture of its transportation and industrial-chemicals unit. The results of all this maneuvering have been just so-so. Dow is up about 9% since the March record date for its separation, lagging the S&P 500 Index and the benchmark’s materials sub-group. Corteva has slumped nearly 6% since its May debut. DuPont itself is down more than 14% so far this year. That’s partly a reflection of the sheer amount of time it took to orchestrate this complicated musical chairs.The merger with Dow was announced four years ago, and the interim waiting period can create a sort of spin purgatory as investors hold off on rewarding a soon-to-be-simpler company with a valuation lift until all the paperwork is signed. And when a process takes that long, you’re bound to become a victim of bad timing. Dow and Corteva were spun off into a terrible market for chemicals as the U.S.-China trade war and a slowing economic backdrop weighed on demand and profit margins. Moody’s Investors Service this month issued its 2020 outlook for the North American and EMEA chemical sector, calling for an average Ebitda decline of about 5% amid soft commodity prices and weak investment trends. DuPont shares, meanwhile, also have been dragged down by its legal fight with a prior spinoff, Chemours Co., over liabilities linked to PFAS, the so-called forever chemical that was used in the manufacturing of Teflon.Breakup enthusiasts would tell you the share slump might have been worse if these businesses were still bundled together and one management team was trying to oversee their competing capital requirements and growth profiles. There’s certainly a logic to this latest deal. Nutrition and biosciences is DuPont’s largest division and has one of the more attractive growth profiles, but DuPont clearly wasn’t getting credit for this business in its stock.The deal with IFF values the DuPont unit at more than 18 times its adjusted Ebitda in the past year, according to data compiled by Bloomberg. That’s well above what the parent company commands. At the same time, there’s a reason the nutrition and biosciences unit commands a higher valuation. The removal of this generally stable business may make it harder for DuPont to prove that its earnings and sales growth can rise above economic volatility.If DuPont follows through on carving out the transportation and industrial unit as well, that would help limit its exposure to the swings in the automotive industry, which has been a particularly tough market of late. But it’s unclear what the endgame is here. There’s something deeply unsatisfying about a company using yet more breakups to fix a valuation disconnect that its first round of breakups was meant to rectify. Eventually, you run out of assets to sell or spin off. (1) Tyco eventually merged with Johnson Controls years after Breen had moved on, and the combined company took the latter’s name.To contact the author of this story: Brooke Sutherland at bsutherland7@bloomberg.netTo contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- ACCESSWIRE
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CC, ACB and HEXO
NEW YORK, NY / ACCESSWIRE / December 9, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...
- Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against The Chemours Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against The Chemours Company
- ACCESSWIRE
CC DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts The Chemours Company (CC) Investors of Today’s Deadline to Move for Lead Plaintiff
SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2019 / Hagens Berman alerts The Chemours Company (NYSE:CC) investors of today's deadline to move for lead plaintiff in a securities fraud class action pending ...
- PR Newswire
CHEMOURS COMPANY 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against The Chemours Company - CC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until December 9, 2019 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased the Company's shares between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
- ACCESSWIRE
CC FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Tomorrow
SAN FRANCISCO, CA / ACCESSWIRE / December 8, 2019 / Hagens Berman urges The Chemours Company (NYSE:CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit ...
- ACCESSWIRE
2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Securities
SAN FRANCISCO, CA / ACCESSWIRE / December 7, 2019 / Hagens Berman urges The Chemours Company (NYSE:CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit ...
- Business Wire
CHEMOURS COMPANY 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against The Chemours Company - CC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until December 9, 2019 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased the Company’s shares between February 16, 2017 and August 1, 2019, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Delaware.
- GlobeNewswire
3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Securities
SAN FRANCISCO, Dec. 06, 2019 -- Hagens Berman urges The Chemours Company (NYSE: CC) investors who have suffered significant losses on Chemours common stock, options and/or.
- ACCESSWIRE
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against The Chemours Company and Encourages Investors with Losses In Excess of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 6, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. If you are a shareholder who suffered a loss, click here to participate.
- ACCESSWIRE
CLASS ACTION UPDATE for ADTN, CC and TEUM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / December 6, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. According to the filed complaint, during the class period, ADTRAN, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company's internal control over financial reporting; (2) as a result, certain E&O reserves had been improperly reported; (3) as a result, the Company's financial results for certain periods were misstated; (4) there would be a pause in shipments to the Company's Latin American customer; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
- GuruFocus.com
What Does David Einhorn Like About Chemours?
A look at a position the hedge fund manager was buying in the third quarter Continue reading...
- Newsfile
Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In The Chemours Company To Contact The Firm
New York, New York--(Newsfile Corp. - December 6, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in The Chemours Company (NYSE: CC) ("Chemours" or the "Company") of the December 9, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi logoIf you invested in Chemours stock or options between February 16, 2017 and ...
- ACCESSWIRE
SHAREHOLDER ALERT: CC TEUM CGC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / December 6, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. Allegations against CC include that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company's policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours' handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.
- GlobeNewswire
DEADLINE ALERT - The Chemours Company (CC) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 9, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or the “Company”) (CC) and certain of its officers, on behalf of shareholders who purchased Chemours securities between February 16, 2017 and August 1, 2019 (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. The Complaint alleges that, throughout the Class Period, Defendants misled investors by representing that Chemours had appropriately accounted and accrued reserves for its environmental liabilities, that the possibility of costs exceeding accrued amounts was "remote," and that, in any event, additional costs would not be material.
- PR Newswire
4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Securities
Hagens Berman urges The Chemours Company (NYSE: CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit their loss now to learn if they qualify to recover their investment losses. The December 9, 2019 lead plaintiff deadline in a securities fraud class action pending against the company is fast approaching.
- ACCESSWIRE
4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against The Chemours Company and Encourages Investors with Losses In Excess of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 5, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. If you are a shareholder who suffered a loss, click here to participate.
